Having just finished a trial of carboplatin + docetaxel, I'll be starting Xofigo next week as a bridge to a pembro+ trial early next year. My latest PSA is 940, with no visible soft tissue involvement. I have a single-strand CDK12 defect. Hoping that the suggestion of this paper is true for me:
Efficacy of Radium-223 in Bone-metastatic Castration-resistant Prostate Cancer with and Without Homologous Repair Gene Defects